Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Electronic Health Record Review, Survey Administration.
- Who it may be relevant to
- Registry conditions: Central Nervous System Neoplasm, Leptomeningeal Neoplasm, Metastatic Malignant Neoplasm in the Brain, Primary Brain Neoplasm. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.
Detailed description
PRIMARY OBJECTIVE:
I. To evaluate the patient-perceived quality of care by group (telemedicine versus in-person visits) in patients with central nervous system (CNS) cancer.
SECONDARY OBJECTIVES:
I. To characterize the visits provided by telemedicine compared to those in-person.
II. To contrast the average time spent on telemedicine visits compared to in-person visits, and the delay between visit order placement and visit occurring.
III. To evaluate the domains of patient care addressed on a telemedicine visit versus in-person visit per documentation, including (1) treatment planning, (2) symptom burden, (3) goals of care.
IV. To evaluate frequency of acute care sought (through emergency room or urgent care clinic) within 30 days of encounter in telemedicine visit versus (vs) in-person visit.
V. The impact of patient and clinical characteristics on perceived quality of care in the context of covariate-adjusted modeling.
OUTLINE:
Patients complete a survey related to their perceived quality of care via telephone and have their medical chart reviewed prospectively.
Interventions
- Other Electronic Health Record Review
Review of medical chart - Other Survey Administration
Complete survey
Primary outcome measures
- Survey response to question 6 of the quality of care survey ("I felt I received good medical care during this encounter") [Time frame: through study completion, an average of 1 year]
Secondary outcome measures (6)
- Quality of Care Survey [Time frame: through study completion, an average of 1 year]
- Patients and clinical characteristics [Time frame: Baseline]
- Interactive time spent during visit [Time frame: through study completion, an average of 1 year]
- Time from visit order placement to visit occurring [Time frame: through study completion, an average of 1 year]
- Domains of patient care addressed during a visit, including treatment planning, symptom burden, and goals of care [Time frame: through study completion, an average of 1 year]
- Incidence of acute care sought (through emergency room or urgent care clinic) [Time frame: Within 30 days of encounter]
Eligibility criteria
Inclusion criteria
- Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease
- Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be
- An in-person visit
- A telemedicine appointment
Exclusion criteria
- Encounter occurred with the assistance of official language translation support
- Patients with telephone encounters (without interactive video)
- New patient or consult visits
- Neither patient nor caregiver present during the visit are available or able to answer survey questions
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- M D Anderson Cancer Center — Houston
Identifiers
NCT: NCT04988009 · 2020-0493 · NCI-2020-07493 · 2020-0493